USPTO serial 99624209
TELEGENIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2026
- Examiner
- KEAN, AMY C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TELEGENIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boca Raton, FL, US
Boca Raton, FL, US
Boca Raton, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Joseph, Jr.
Jeffrey A. Joseph, Jr. Brennan, Manna & Diamond, LLC75 E Market StreetAkron, OH 44308United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Medical services provided via telemedicine and remote consultation; Telehealth medical consultations; Hormone replacement therapy services; Healthcare services, namely peptide therapy services for health optimization and wellness, namely, use of peptide-based therapies to support weight management, energy levels, sleep quality, hormonal balance, cognitive function, recovery, and overall patient well-being, with treatment protocols tailored to the individual needs of each patient; Longevity regenerative medicine services; Preventive healthcare services; Medical counseling in the fields of hormone balance, metabolic health, and anti-aging; Providing personalized medical and wellness programs through licensed healthcare professionals namely, developing and administering individualized treatment protocols based on a patient's medical history, health goals, laboratory testing, blood work, and clinical needs, including the prescription and management of medications, hormone therapies, peptides, and other therapeutic treatments, wherein each protocol is customized for the individual patient and may include one or more peptide therapies as determined by the licensed healthcare professional; Medical diagnostic testing for treatment and health optimization purposes; Health and wellness monitoring in the nature of evaluating and monitoring patient health through laboratory testing, blood work analysis, physician assessments, and patient-reported outcomes, including responses regarding physical well-being, mood, sleep quality, recovery, and other health indicators, for the purpose of developing, adjusting, and managing individualized treatment and wellness protocols; Medical analysis relating to longevity, hormone replacement therapy, and age-related health management; providing healthcare information via secure telecommunication networks. | ACTIVE | Jan 1, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 25, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 10, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2026 | NWAP | NEW APPLICATION ENTERED | — |